Press "Enter" to skip to content

What’s new in cancer treatment | Emanuela Palmerini | TEDxPadova


[Music]
Good morning everyone I am an oncologist
medical cancers but you know
What is a cancer tumor is a set
of cells and our fabrics are
usually consist of cells that are
divided by a delicate balance
But for so many cells that form
many will die then the number
Final remains the same as in tumors
this mechanism end adjustment
It is to get lost and cancer tumors
these cells that grow in a manner
uncontrolled occupying the whole space
to them for more than 60 years
we use chemotherapy and I want
say with great clarity the
Chemotherapy for cancer work
the problem is that I have some how
cruise missiles at Donald Trump
specific or kills all cells
that proliferate in the bad ones
cancer but also the good ones like
as those of the hair follicles or ca
blood in recent years we have
We made major progress, and we are
passed from chemotherapy
much more specific treatments
example, the target therapy therapy
molecular target
are so-called smart drugs
ie those able to figure out who he is
the cell to hit the one that
He has a kind of membrane receptor
label that allows us to precisely
recognize
the next step and that is to which
I would like to talk today
immunotherapy extremely
fascinating or the ability of the
Our own immune system
eliminate cells recognized as
different in the future
pharmacogenomics or identify
the more active and less treatment
Toxic for each of us
if the change of perspective
In fact we want is revolutionary
passed by the cell or the cell
with its membrane receptor
what’s around
or the macro environment or food
tumor microenvironment are cells like
lymphocytes and dendritic cells
macrophages but let’s step back
I deal specifically sarcoma
are extremely rare aggressive tumors
debut typically between 14 and 16
years, and mainly affect the bone
and then spread to tissues
surrounding the fundamental treatment
It is represented by the surgery as
for many solid tumors but not alone
just the probability of cure with
surgery alone of only 10 percent
because 9 out of 10 patients fall as
taxanes psi lungs after only a few
months after surgery and this chart
shows the significant changes and
improvements we have that we
attended from 1960 to 2010 with a
increased survival 10-65
percent and that you see the blue line
high thanks to the introduction of
chemotherapy for more placing the
chemotherapy
before surgery the
need to resort to amputation
It fell from 90 to less than 5 percent
but there is a problem, the problem of
this curve is to the left or
is a flat line there were no
plus further progress in the past
years
the reason is simple no new
drug approved for lost sarcoma
for more than 20 years, despite truly
many are the studies and researches
finally something happens in 2009
but the European Agency for the drug
endorse the myrtle trees it makes me a
immunostimulant for this tumor
the idea of using our own
immune system against tumors
or vaccinated against a cell
as we do for tumor viruses it has to
always fascinated doctors and
researchers and is possible because
There are on the tumor cells
so-called antigens in the proteins of
membrane that allow the
recognition
the problem is efficiency
elimination or this system
He recognizes very well but then does not eliminate
The cancer also are responsible for
its knowledge are mainly the
These lymphocytes immune cells
that the optical microscope as you see
They are all very simple and homogeneous in
reality are part of a system
extremely complex we find in
blood in the primary lymphoid organs and
Secondary such as spleen and
lymph nodes
Finally, even within our own
just inside tumors and these tumors
that research of my began
laboratory
In fact, we analyzed biopsies
real beginning of any tissue
treating more than 100 patients
all they had less than 40 years
all had a diagnosis of
osteosarcoma localized onset
All had been treated with the same
chemotherapy protocol and
same surgical team then
They were supposed to have chance
very similar healing
what we have seen is
when in fact profoundly different
these fabrics were not present
lymphocytes that these soldiers
the likelihood of immunity
Healing was below 150
one hundred
when they were instead present since
beginning the probability saliva
more than eighty percent
it would probably be very important
differentiating pay since
start and use
together with immunotherapy
chemotherapy in the subgroup precisely
lymphocytes without the good news is that
these drugs are now available
They are called inhibitors of checkpoint
I do not know if you’ve heard but
does not surprise me because in the past
almost three years in various tumors
see melanoma but also kidney cancer
really aggressive cancers such as cancers
lung cancer were
approved what it’s approved it
I can say that I prescribe them but
first it proved an important
increased survival in the group
which they were used for the lung
even get to four times more
and these drugs act by binding and
to the cell membrane
precisely immunity by stimulating the
stimulating sarcomas are a bit
back
I present a single case presented
last year by a collaborative group
American see is a metastasis
lung in the circle in red treated
with pd inhibitors and one after two months
we see a major reduction
This metastases and 8 months we have a
almost disappearance of all
lung metastases in Italy we are
moving on two fronts
preclinical research in my
Lab have developed a
model with dendritic cells and two
cellular lines of sarcoma of the innkeeper
soft tissue sarcomas study
Only immunotherapy but the best
combination of the single-topic and
for example inhibitors of angiogenesis
from the clinical side of this year
sarcoma patients will have
access to two different clinical trials
experimental in bologna 1
collaboration with the University of Oslo
and the second in collaboration with the
Spanish group for the future sarcomas
It will be a further change
perspective from the cell we
He looked around the cell pitch
will look forward to the container
same tumor
namely the guest the patient himself
In fact, large great commitment in this
say new legislation is called
pharmacogenomics in simple words
using genetic information does not
only a specific cancer but also
his guest the patient to predict
whether a treatment will be active or
toxic to a particular individual
what we call medicine
personalized
I want to tell you now though
More importantly researched
really take years and then think
it is useful that now everyone
do something to improve
likely to have a tumor
or follow a proper lifestyle
and it is easy just follow the
rules such as Rule 05 30
0 or five cigarettes a day
Sometimes Sometimes meals of fruit or
vegetables and 30 minutes of physical activity
per day
First to greet you, and I wanted
together we listen this song
[Music]
You acknowledge the children and it is called
one of the most important works of one
of the greatest DJs of Ibiza and the world
robert miles robert miles is dead
this week for a tumor after only
nine months
so I dedicate my research to all
people who like him have fought
against tumors that do not yet
we know enough
thank you
[Applause]
Please follow and like us: